Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × BO-112 × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Basal Cell 1

Interventions

Specimen Handling 219 pembrolizumab 199 Magnetic Resonance Spectroscopy 179 Biopsy 133 Carboplatin 130 Cyclophosphamide 115 Nivolumab 108 Cisplatin 104 Paclitaxel 98 Radiotherapy 85 Gemcitabine 70 Bevacizumab 69 venetoclax 67 durvalumab 64 Dexamethasone 64 Oxaliplatin 57 Docetaxel 56 atezolizumab 55 Ipilimumab 55 Capecitabine 55 fludarabine 54 Rituximab 54 Fluorouracil 54 Prednisone 52 Radiation 49 olaparib 48 Etoposide 48 Radiosurgery 46 Drug Therapy 46 Cytarabine 46

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06422936 2026-01-26

SPOTLIGHT204

Highlight Therapeutics

Phase 2 Active not recruiting

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡